Send mail to Author

Benefit of treatment individualization in patients with chronic hepatitis C receiving peginterferon alfa-2a and ribavirin in a large noninterventional cohort study (Article)

Please indicate your contact information and select, which author you want to contact.



 
   _____   __   __   _____       ___     _    _      ___    
  / ___//  \ \\/ // |  __ \\    / _ \\  | \  / ||   / _ \\  
  \___ \\   \ ` //  | |  \ ||  | / \ || |  \/  ||  / //\ \\ 
  /    //    | ||   | |__/ ||  | \_/ || | .  . || |  ___  ||
 /____//     |_||   |_____//    \___//  |_|\/|_|| |_||  |_||
`-----`      `-`'    -----`     `---`   `-`  `-`  `-`   `-` 
                                                            
 


Back to frontdoor view